Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM GLUCONATE versus HEMICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM GLUCONATE versus HEMICLOR.
CALCIUM GLUCONATE vs HEMICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium gluconate dissociates to provide calcium ions, which are essential for nerve impulse transmission, muscle contraction, cardiac function, and blood coagulation. It acts as a mineral electrolyte replenisher.
Hemichlor (HEMICLOR) is a brand name for a combination product containing chlorpheniramine and pseudoephedrine. Chlorpheniramine is a first-generation antihistamine that antagonizes histamine at H1 receptor sites, reducing allergic symptoms. Pseudoephedrine is a sympathomimetic amine that directly stimulates alpha-adrenergic receptors, causing vasoconstriction and decongestion.
Intravenous: 1-2 grams (10-20 mL of 10% solution) administered slowly over 5-10 minutes. May repeat based on serum calcium levels.
50-100 mg intravenously every 6 hours or 100 mg orally every 12 hours.
None Documented
None Documented
Clinical Note
moderateCalcium gluconate + Clodronic acid
"The serum concentration of Clodronic acid can be decreased when it is combined with Calcium gluconate."
Clinical Note
moderateCalcium gluconate + Tranilast
"The therapeutic efficacy of Tranilast can be decreased when used in combination with Calcium gluconate."
Clinical Note
moderateCalcium gluconate + Alendronic acid
"The serum concentration of Alendronic acid can be decreased when it is combined with Calcium gluconate."
Clinical Note
moderateRapid distribution half-life ~5-10 min; terminal half-life 3-6 hours due to redistribution and renal excretion; clinically, effect duration is short (1-2 hours) due to rapid redistribution into bone and other tissues.
Terminal elimination half-life 18–24 hours in normal renal function; prolonged to 36–48 hours in moderate renal impairment (CrCl 30–50 mL/min); adjust dosing interval in renal disease.
Primarily renal (calcium is filtered and reabsorbed); negligible biliary/fecal. >98% of body calcium is in bone; excretion is complex and homeostatically regulated.
Primarily renal (85–90% as unchanged drug via glomerular filtration and tubular secretion); biliary/fecal < 5%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement
Calcium gluconate + Technetium Tc-99m medronate
"The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Calcium gluconate."